Predicting neo‐adjuvant chemotherapy response and progression‐free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F‐18 FDG PET / CT and diffusion‐weighted MR imaging-Reference-Cited by-同舟云学术

Predicting neo‐adjuvant chemotherapy response and progression‐free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F‐18 FDG PET / CT and diffusion‐weighted MR imaging

Published:2018-03-30 Issue:3 Volume:25 Page:373-380
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Yoon Hai‐Jeon¹,Kim Yemi²,Chung Jin³,Kim Bom Sahn¹²

Affiliation:

1. Department of Nuclear Medicine Ewha Womans University Seoul Korea

2. Clinical Research Institute Ewha Womans University Seoul Korea

3. Department of Radiology Ewha Womans University Seoul Korea

Funder

National Research Foundation of Korea

Ewha Womans University

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13032

Reference27 articles.

1. Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

2. Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression

3. Intratumor heterogeneity: Nature and biological significance

4. Neoadjuvant treatment of breast cancer

5. Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peritumoral Adipose Tissue Features Derived from [18F]fluoro-2-deoxy-2-d-glucose Positron Emission Tomography/Computed Tomography as Predictors for Response to Neoadjuvant Chemotherapy in Breast Cancer Patients;Journal of Personalized Medicine;2024-09-09

2. Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer;EJNMMI Research;2024-07-04

3. Baseline [18F]FDG PET/CT and MRI first-order breast tumor features do not improve pathological complete response prediction to neoadjuvant chemotherapy;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-26

4. Análisis radiómico PET intra y peritumoral para predecir la respuesta patológica en pacientes con cáncer de mama que reciben quimioterapia neoadyuvante;Revista Española de Medicina Nuclear e Imagen Molecular;2024-05

5. Intra and peritumoral PET radiomics analysis to predict the pathological response in breast cancer patients receiving neoadjuvant chemotherapy;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2024-05